awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55457289-426259ED-FAFE-41E3-BE51-AB4CAE4DC0C0
Q55457289-426259ED-FAFE-41E3-BE51-AB4CAE4DC0C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55457289-426259ED-FAFE-41E3-BE51-AB4CAE4DC0C0
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma.
P2860
Q55457289-426259ED-FAFE-41E3-BE51-AB4CAE4DC0C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55457289-426259ED-FAFE-41E3-BE51-AB4CAE4DC0C0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
475f93d2b64f8e324001d469c6f0dd3b15ca6423
P2860
Lomustine and Bevacizumab in Progressive Glioblastoma.